France has officially banned the sale of nicotine pouches, a decision that has sparked criticism from public health experts who argue that these products are among the most effective tools for quitting smoking.
On February 25, the French government submitted a draft decree to the European Union, signaling a significant shift in its approach to tobacco control. The move follows a parliamentary vote earlier in February that prohibited disposable e-cigarettes.
Critics contend that these bans limit access to smoke-free alternatives, despite previous government statements advocating a more flexible stance under the National Tobacco Control Program 2023-2027. French officials justify the prohibition by citing concerns over youth usage. However, industry leaders argue the decision disregards scientific evidence, according to media reports.
British American Tobacco (BAT) France condemned the ban as “outrageous,” noting that France’s Conseil d’État had previously ruled a similar restriction as “disproportionate.” Supporters of nicotine pouches maintain that these products, which contain nicotine but no tobacco, are a safer alternative to traditional cigarettes. Opponents of the ban fear it may drive consumers toward illicit markets or back to combustible tobacco.
“We don’t just need a smoke-free generation, we need a nicotine-free generation,” said Estonian Health Minister Riina Sikkut in a statement to Euractiv, reflecting the stance of some European policymakers. France now aligns with Germany, Austria, Belgium, and Luxembourg, which have also banned nicotine pouches. However, at the EU level, nicotine pouches remain unregulated due to the 2014 Tobacco Products Directive, which covers tobacco-containing products but excludes tobacco-free alternatives.
Meanwhile, Canada treats nicotine pouches similarly to other nicotine products under federal regulations. Zonnic is currently the only officially licensed brand, approved by Health Canada as a nicotine replacement therapy available in pharmacies, though an unregulated online market persists.
With the European nicotine pouch market expected to grow 6.2% annually, reaching an estimated €1.06 billion ($1.6 billion) by 2030, major companies such as Philip Morris International, Imperial Brands, and Japan Tobacco International have heavily invested in the sector. They argue that these alternatives should not be regulated like traditional cigarettes and that policymakers should adopt a balanced regulatory approach.
Some industry experts believe Poland’s EU Council presidency could prompt broader discussions on taxation and regulation for alternative tobacco products. Certain European health ministers have urged the European Commission to address the issue, warning that legal loopholes continue to be exploited by companies.
BAT France and others had advocated for regulation instead of an outright ban, proposing measures such as restricting sales to minors, capping nicotine levels, and limiting marketing. However, the French government proceeded with the prohibition, citing rising youth usage and the need for strict public health measures.
The long-term effects of the ban remain uncertain—whether it will reduce youth consumption, fuel illegal sales, or encourage an EU-wide crackdown. For now, many smokers who rely on nicotine pouches for quitting support are left without a legal alternative as France enforces its stricter stance on the emerging industry.
